STAND Against Emerging Opioids Act
In committee: it can still change before the session ends.
- Stage
- In committee
- Started in
- House
- Sponsors
- 3
- Latest action
- May 20, 2025
What it does
The STAND Against Emerging Opioids Act would amend the Controlled Substances Act to classify tianeptine, including its analogues, salts, isomers, and salts of isomers, as a Schedule III controlled substance. This change would subject tianeptine to federal regulations governing its manufacture, distribution, and possession, aiming to address its emerging misuse as an opioid-like substance. The scheduling would take effect 90 days after the bill’s enactment. The bill affects individuals, manufacturers, distributors, and healthcare providers involved with tianeptine, and it has been referred to the House Committees on Energy and Commerce and the Judiciary for further consideration.
No official summary is available here. This one was written by AI from the bill’s text.
Where it stands
Introduced (Done)
Committee (Current step)
Floor (Not started)
Law (Not started)
What moved
Who is involved
Sponsors
The lawmakers who put their names on it, lead sponsors first.
Where it goes next
While a bill can still move, the questions are about people and money.